Involvement of the pleiotropic drug resistance response, protein kinase C signaling, and altered zinc homeostasis in resistance of Saccharomyces cerevisiae to diclofenac

Applied and Environmental Microbiology

Volumn 77, Issue 17, 2011, Pages 5973-5980

  van Leeuwen, Jolanda S ^a   Vermeulen, Nico P E ^a   Vos, J Chris ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 ,10-PHENANTHROLINE; ADVERSE DRUG REACTIONS; ANALGESIC DRUGS; CALCOFLUOR WHITE; CELL WALLS; DICLOFENAC; DRUG RESISTANCE; DRUG RESISTANCE GENES; MICROARRAY ANALYSIS; MOLECULAR MECHANISM; MULTIDRUG TRANSPORTERS; PROTEIN KINASE C; RIBOSOME BIOGENESIS; RRNA PROCESSING; YEAST CELL; ZINC CHELATOR;

CELLS; DETOXIFICATION; DRUG PRODUCTS; ENZYMES; FLOCCULATION; GENES; PHYSIOLOGY; RNA; SIGNALING; TOXICITY; TRANSCRIPTION; TRANSCRIPTION FACTORS; YEAST;

ZINC;

ABC TRANSPORTER; ANTIFUNGAL AGENT; DICLOFENAC; PDR5 PROTEIN, S CEREVISIAE; PKC1 PROTEIN, S CEREVISIAE; PROTEIN KINASE C; SACCHAROMYCES CEREVISIAE PROTEIN; TRANSCRIPTION FACTOR; ZAP1 PROTEIN, S CEREVISIAE; ZINC;

CYTOLOGY; DRUG RESISTANCE; ENZYME ACTIVITY; EUKARYOTE; FLOCCULATION; HOMEOSTASIS; MOLECULAR ANALYSIS; PROTEIN; SIGNALING; SURVIVAL; TOXICITY; YEAST;

ANTIFUNGAL RESISTANCE; ARTICLE; DRUG EFFECT; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MICROARRAY ANALYSIS; MICROBIAL VIABILITY; SACCHAROMYCES CEREVISIAE; SIGNAL TRANSDUCTION;

ANTIFUNGAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DICLOFENAC; DRUG RESISTANCE, FUNGAL; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; MICROBIAL VIABILITY; PROTEIN KINASE C; SACCHAROMYCES CEREVISIAE; SACCHAROMYCES CEREVISIAE PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; ZINC;

EUKARYOTA; SACCHAROMYCES CEREVISIAE;

EID: 80052699817     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00253-11     Document Type: Article

References (47)

1. Abbott, D. A., E. Suir, A. J. van Maris, and J. T. Pronk. 2008. Physiological and transcriptional responses to high concentrations of lactic acid in anaerobic chemostat cultures of Saccharomyces cerevisiae. Appl. Environ. Microbiol. 74:5759-5768.
2. Abou-Mohamed, G., H. A. el-Kashef, H. A. Salem, and M. M. Elmazar. 1995. Effect of zinc on the anti-inflammatory and ulcerogenic activities of indometacin and diclofenac. Pharmacology 50:266-272.
3. Alem, M. A., and L. J. Douglas. 2004. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob. Agents Chemother. 48:41-47.
4. Boorsma, A., B. C. Foat, D. Vis, F. Klis, and H. J. Bussemaker. 2005. T-profiler: scoring the activity of predefined groups of genes using gene expression data. Nucleic Acids Res. 33:W592-W595.
5. Carvajal, E., H. B. van den Hazel, A. Cybularz-Kolaczkowska, E. Balzi, and A. Goffeau. 1997. Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes. Mol. Gen. Genet. 256:406-415.
6. Causton, H. C., et al. 2001. Remodeling of yeast genome expression in response to environmental changes. Mol. Biol. Cell 12:323-337.
7. Chung, H., et al. 2006. Comprehensive analysis of differential gene expression profiles on diclofenac-induced acute mouse liver injury and recovery. Toxicol. Lett. 166:77-87.
8. Decottignies, A., et al. 1995. Identification and characterization of SNQ2, a new multidrug ATP binding cassette transporter of the yeast plasma membrane. J. Biol. Chem. 270:18150-18157.
9. Deng, X., et al. 2008. Gene expression profiles in livers from diclofenactreated rats reveal intestinal bacteria-dependent and -independent pathways associated with liver injury. J. Pharmacol. Exp. Ther. 327:634-644.
10. Fardeau, V., et al. 2007. The central role of PDR1 in the foundation of yeast drug resistance. J. Biol. Chem. 282:5063-5074.
11. Fosbol, E. L., et al. 2009. Risk of myocardial infarction and death associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) among healthy individuals: a nationwide cohort study. Clin. Pharmacol. Ther. 85:190-197.
12. Gasch, A. P., et al. 2000. Genomic expression programs in the response of yeast cells to environmental changes. Mol. Biol. Cell 11:4241-4257.
13. Giaever, G., et al. 2002. Functional profiling of the Saccharomyces cerevisiae genome. Nature 418:387-391.
14. Giaever, G., et al. 2004. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc. Natl. Acad. Sci. U. S. A. 101:793-798.
15. Gomez-Lechon, M. J., et al. 2003. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem. Pharmacol. 66:2155-2167.
16. Hallstrom, T. C., and W. S. Moye-Rowley. 2000. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J. Biol. Chem. 275:37347-37356.
17. Hazelwood, L. A., M. C. Walsh, J. T. Pronk, and J. M. Daran. 2010. Involvement of vacuolar sequestration and active transport in tolerance of Saccharomyces cerevisiae to hop iso-α-acids. Appl. Environ. Microbiol. 76:318-328.
18. Herbig, A., et al. 2005. Zap1 activation domain 1 and its role in controlling gene expression in response to cellular zinc status. Mol. Microbiol. 57:834-846.
19. Hillenmeyer, M. E., et al. 2008. The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science 320:362-365.
20. Hoon, S., R. P. St Onge, G. Giaever, and C. Nislow. 2008. Yeast chemical genomics and drug discovery: an update. Trends Pharmacol. Sci. 29:499-504.
21. Katzmann, D. J., P. E. Burnett, J. Golin, Y. Mahe, and W. S. Moye-Rowley. 1994. Transcriptional control of the yeast PDR5 gene by the PDR3 gene product. Mol. Cell. Biol. 14:4653-4661.
22. Kemmer, D., et al. 2009. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis. BMC Microbiol. 9:9.
23. Klebe, R. J., J. V. Harriss, Z. D. Sharp, and M. G. Douglas. 1983. A general method for polyethylene-glycol-induced genetic transformation of bacteria and yeast. Gene 25:333-341.
24. Lagas, J. S., C. M. van der Kruijssen, K. van de Wetering, J. H. Beijnen, and A. H. Schinkel. 2009. Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone. Drug Metab. Dispos. 37:129-136.
25. Laine, L., et al. 2009. How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial. Am. J. Gastroenterol. 104:356-362.
26. Lauer, B., G. Tuschl, M. Kling, and S. O. Mueller. 2009. Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes. Chem. Biol. Interact. 179:17-24.
27. Legras, J. L., et al. 2010. Activation of two different resistance mechanisms in Saccharomyces cerevisiae upon exposure to octanoic and decanoic acids. Appl. Environ. Microbiol. 76:7526-7535.
28. Levin, D. E. 2005. Cell wall integrity signaling in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev. 69:262-291.
29. Lewis, S. C., et al. 2002. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br. J. Clin. Pharmacol. 54:320-326.
30. Lim, M. S., P. L. Lim, R. Gupta, and U. A. Boelsterli. 2006. Critical role of free cytosolic calcium, but not uncoupling, in mitochondrial permeability transition and cell death induced by diclofenac oxidative metabolites in immortalized human hepatocytes. Toxicol. Appl. Pharmacol. 217:322-331.
31. Luesch, H., et al. 2005. A genome-wide overexpression screen in yeast for small-molecule target identification. Chem. Biol. 12:55-63.
32. Mager, W. H., and J. Winderickx. 2005. Yeast as a model for medical and medicinal research. Trends Pharmacol. Sci. 26:265-273.
33. Mahé, Y., Y. Lemoine, and K. Kuchler. 1996. The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo. J. Biol. Chem. 271:25167-25172.
34. Mima, S., et al. 2007. Identification of the TPO1 gene in yeast, and its human orthologue TETRAN, which cause resistance to NSAIDs. FEBS Lett. 581:1457-1463.
35. Mira, N. P., M. C. Teixeira, and I. Sa-Correia. 2010. Adaptive response and tolerance to weak acids in Saccharomyces cerevisiae: a genome-wide view. Omics 14:525-540.
36. Moye-Rowley, W. S. 2003. Transcriptional control of multidrug resistance in the yeast Saccharomyces. Prog. Nucleic Acid Res. Mol. Biol. 73:251-279.
37. Oaks, J. L., et al. 2004. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630-633.
38. Panwar, S. L., and W. S. Moye-Rowley. 2006. Long chain base tolerance in Saccharomyces cerevisiae is induced by retrograde signals from the mitochondria. J. Biol. Chem. 281:6376-6384.
39. Powell, S. R. 2000. The antioxidant properties of zinc. J. Nutr. 130:1447S-1454S.
40. Shahi, P., and W. S. Moye-Rowley. 2009. Coordinate control of lipid composition and drug transport activities is required for normal multidrug resistance in fungi. Biochim. Biophys. Acta 1794:852-859.
41. Shoji, S., H. Miyamoto, and S. Nomoto. 1993. Adverse effect of antipyretic agent on serum zinc. Ann. Clin. Lab. Sci. 23:106-110.
42. Tamas, M. J., et al. 1999. Fps1p controls the accumulation and release of the compatible solute glycerol in yeast osmoregulation. Mol. Microbiol. 31:1087-1104.
43. van Leeuwen, J. S., et al. 2011. Subunits Rip1p and Cox9p of the respiratory chain contribute to diclofenac-induced mitochondrial dysfunction. Microbiology 157:685-694.
44. van Leeuwen, J. S., et al. 2011. Metabolism related toxicity of diclofenac in yeast as model system. Toxicol. Lett. 200:162-168.
45. Yasokawa, D., and H. Iwahashi. 2010. Toxicogenomics using yeast DNA microarrays. J. Biosci. Bioeng. 110:511-522.
46. Zakrzewska, A., et al. 2010. Comparative analysis of transcriptome and fitness profiles reveals general and condition-specific cellular functions involved in adaptation to environmental change in Saccharomyces cerevisiae. Omics 14:603-614.
47. Zhou, T., J. Chou, P. B. Watkins, and W. K. Kaufmann. 2009. Toxicogenomics: transcription profiling for toxicology assessment. EXS 99:325-366.